Trademark: 97454585
Word
NEDNA
Status
Pending
Status Code
807
Status Date
Friday, March 8, 2024
Serial Number
97454585
Mark Type
4000
Filing Date
Sunday, June 12, 2022
Published for Opposition
Tuesday, May 30, 2023

Trademark Owner History
Asklepios BioPharmaceutical, Inc. - Owner At Publication

Classifications
5 Vaccines; DNA based vaccines; DNA extracts, namely, nucleic acid sequences and chemical reagents for medical use; therapeutic DNA, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes; biotechnological product, namely, viral DNA vectors, for the delivery of genes and other materials in the nature of RNA and transcriptional targeting promoters, to a biological cell for medical purposes; biological preparations, namely, DNA extracts for production of viral vectors for medical purposes
1 Chemical preparations, enzymes, DNA vectors, and DNA extracts for the preparation of nucleic acid for scientific and research purposes; chemicals for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; enzymes for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; DNA extracts and cassettes for scientific and research use; DNA extracts for scientific and research purposes in the fields of agri-biotechnology and nanotechnology; biological and biochemical reagents being RNA polymerase, DNA polymerase, DNA plasmid vectors, DNA vectors, rAAV vectors, and RNA markers that form a gene analysis system not for medical purposes; diagnostic reagents for scientific or research purposes, namely, a diagnostic kit consisting primarily of DNA plasmid vectors
42 Scientific and technological services, namely, research and design in the field of DNA research and development; chemical and biological analysis and research services; scientific research in the field of DNA; scientific research and development in the field of creating of DNA extracts; scientific and technological services, namely, scientific research, analysis, design and development in the field of DNA based pharmaceutical drugs and therapies; scientific research and development in the fields of gene therapy, diagnostics, agri-biotechnology and nanotechnology; scientific consultancy services in the fields of gene therapy, diagnostics, agri-biotechnology, nano technology, and DNA analysis

Trademark Events
Mar 8, 2024
Notification Of Non-Final Action E-Mailed
Mar 8, 2024
Non-Final Action E-Mailed
Mar 8, 2024
Su - Non-Final Action - Written
Feb 2, 2024
Statement Of Use Processing Complete
Jan 11, 2024
Use Amendment Filed
Feb 2, 2024
Case Assigned To Intent To Use Paralegal
Jan 11, 2024
Teas Statement Of Use Received
Jul 25, 2023
Noa E-Mailed - Sou Required From Applicant
May 30, 2023
Official Gazette Publication Confirmation E-Mailed
May 30, 2023
Published For Opposition
May 10, 2023
Notification Of Notice Of Publication E-Mailed
Apr 21, 2023
Approved For Pub - Principal Register
Apr 20, 2023
Teas/Email Correspondence Entered
Apr 19, 2023
Correspondence Received In Law Office
Apr 19, 2023
Teas Response To Office Action Received
Mar 25, 2023
Notification Of Non-Final Action E-Mailed
Mar 25, 2023
Non-Final Action E-Mailed
Mar 25, 2023
Non-Final Action Written
Mar 25, 2023
Assigned To Examiner
Jun 23, 2022
New Application Office Supplied Data Entered
Jun 15, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24